Line 74: | Line 74: | ||
</ul><br> | </ul><br> | ||
<h1> Need to put logos here!</h1> | <h1> Need to put logos here!</h1> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<div class="button_click" onClick=" parent.location= 'https://2016.igem.org/Special:Upload '"> | <div class="button_click" onClick=" parent.location= 'https://2016.igem.org/Special:Upload '"> | ||
Line 105: | Line 79: | ||
</div> | </div> | ||
− | + | ||
Revision as of 17:05, 17 October 2016
-
Read more about endometriosis
-
We created new, synthetic promoters to respond to this disease marker
-
We characterized miRNA profiles in model cells under varying conditions
-
We characterized a serine integrase, TP901, that could give a genetic circuit memory across a cycle
-
Read about a summary of our results and how our sensors interact logically after transfection of
4 to 5-unit genetic circuits into model cell cultures
-
Read about how we worked with other iGEM teams throughout our project
-
Read more about the future of our work through circuit design and clinical application
-
Read more about our integrated human practices, mammalian synthetic biology toolbox, and public outreach
-
Read more
-
Read more